您的位置: 首页 > 农业专利 > 详情页

Continuous administration of cilengitide in cancer treatments
专利权人:
MERCK PATENT GMBH
发明人:
Picard, Martin Andreas,Bethe, Ullrich,Dotzauer, Matthias,Moyal, Elizabeth Cohen-Jonathan
申请号:
AU2010252280
公开号:
AU2010252280A1
申请日:
2010.05.25
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising the continuous administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agent or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充